These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

909 related articles for article (PubMed ID: 9647261)

  • 21. Role of RANTES in the development of autoimmune tissue injuries in MRL-Fas lpr mice.
    Tsukahara T; Makino Y; Fujii T; Ogawa M; Saisho H; Hamano Y; Ueda S; Akikusa B; Danoff TM
    Clin Immunol; 2002 Apr; 103(1):89-97. PubMed ID: 11987989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
    J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A central role for CD95 (Fas) in T-cell reactivity after injury.
    Kell MR; Shelley O; Mannick JA; Guo Z; Lederer JA
    Surgery; 2000 Aug; 128(2):159-64. PubMed ID: 10922986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.
    Patole PS; Gröne HJ; Segerer S; Ciubar R; Belemezova E; Henger A; Kretzler M; Schlöndorff D; Anders HJ
    J Am Soc Nephrol; 2005 May; 16(5):1326-38. PubMed ID: 15772251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attenuation of autoimmune disease in Fas-deficient mice by treatment with a cytotoxic benzodiazepine.
    Bednarski JJ; Warner RE; Rao T; Leonetti F; Yung R; Richardson BC; Johnson KJ; Ellman JA; Opipari AW; Glick GD
    Arthritis Rheum; 2003 Mar; 48(3):757-66. PubMed ID: 12632430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Greatly accelerated lymphadenopathy and autoimmune disease in lpr mice lacking tumor necrosis factor receptor I.
    Zhou T; Edwards CK; Yang P; Wang Z; Bluethmann H; Mountz JD
    J Immunol; 1996 Apr; 156(8):2661-5. PubMed ID: 8609380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central T cell tolerance in lupus-prone mice: influence of autoimmune background and the lpr mutation.
    Fatenejad S; Peng SL; Disorbo O; Craft J
    J Immunol; 1998 Dec; 161(11):6427-32. PubMed ID: 9834135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pivotal role of colony stimulating factor-1 in lupus nephritis.
    Rubin Kelley V; Bloom RD; Yui MA; Martin C; Price D
    Kidney Int Suppl; 1994 Feb; 45():S83-5. PubMed ID: 8158905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lupus nephritis reoccurs following transplantation in the lupus prone mouse.
    Hamar P; Wang M; Godo M; Kokeny G; Rosivall L; Ouyang N; Heemann U
    Lupus; 2010 Feb; 19(2):175-81. PubMed ID: 19946036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perforin protects against autoimmunity in lupus-prone mice.
    Peng SL; Moslehi J; Robert ME; Craft J
    J Immunol; 1998 Jan; 160(2):652-60. PubMed ID: 9551899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fas on renal parenchymal cells does not promote autoimmune nephritis in MRL mice.
    Wada T; Schwarting A; Kinoshita K; Naito T; Griffiths RC; Coffman TM; Kelley VR
    Kidney Int; 1999 Mar; 55(3):841-51. PubMed ID: 10027921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nrf2 deficiency improves autoimmune nephritis caused by the fas mutation lpr.
    Morito N; Yoh K; Hirayama A; Itoh K; Nose M; Koyama A; Yamamoto M; Takahashi S
    Kidney Int; 2004 May; 65(5):1703-13. PubMed ID: 15086909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
    Ashany D; Savir A; Bhardwaj N; Elkon KB
    J Immunol; 1999 Nov; 163(10):5303-11. PubMed ID: 10553053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes.
    Tagawa Y; Sekikawa K; Iwakura Y
    J Immunol; 1997 Aug; 159(3):1418-28. PubMed ID: 9233639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dendritic cells contribute to autoimmune kidney injury in MRL-Faslpr mice.
    Iwata Y; Furuichi K; Sakai N; Yamauchi H; Shinozaki Y; Zhou H; Kurokawa Y; Toyama T; Kitajima S; Okumura T; Yamada S; Maruyama I; Matsushima K; Kaneko S; Wada T
    J Rheumatol; 2009 Feb; 36(2):306-14. PubMed ID: 19208562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity.
    Chan OT; Madaio MP; Shlomchik MJ
    J Immunol; 1999 Oct; 163(7):3592-6. PubMed ID: 10490951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel and enhanced IL-1 gene expression in autoimmune mice with lupus.
    Boswell JM; Yui MA; Endres S; Burt DW; Kelley VE
    J Immunol; 1988 Jul; 141(1):118-24. PubMed ID: 3259964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice.
    Miyazaki T; Ono M; Qu WM; Zhang MC; Mori S; Nakatsuru S; Nakamura Y; Sawasaki T; Endo Y; Nose M
    Eur J Immunol; 2005 May; 35(5):1510-20. PubMed ID: 15832294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice.
    Sadanaga A; Nakashima H; Masutani K; Miyake K; Shimizu S; Igawa T; Sugiyama N; Niiro H; Hirakata H; Harada M
    Arthritis Rheum; 2005 Dec; 52(12):3987-96. PubMed ID: 16320345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-34-Dependent Intrarenal and Systemic Mechanisms Promote Lupus Nephritis in MRL-
    Wada Y; Gonzalez-Sanchez HM; Weinmann-Menke J; Iwata Y; Ajay AK; Meineck M; Kelley VR
    J Am Soc Nephrol; 2019 Feb; 30(2):244-259. PubMed ID: 30622154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.